Cullinan Therapeutics (CGEM) Q1 2023 Earnings

11MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-1.42
0.86
3.14
5.42

Details

Expected EPS
-0.98
Actual EPS
-1.42
Surprise EPS
-0.44
Surprise Percent
+44.9%

Description

Cullinan Therapeutics (CGEM) has reported earnings of -1.42 per share for Q1 2023.

0 Comments

Share your thoughts